Syntopix was spun-out of Leeds University in 2003 with the backing of IP Group. It is involved in developing treatments for antibiotic resistance and diseases of the skin. Syntopix joined Aim on 23 March 2006, when it raised £4m (£3.3m net) at 177p a share.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds